amifostine anhydrous has been researched along with Anaphylaxis in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
Excerpt | Relevance | Reference |
---|---|---|
"Dermatomyositis is associated with malignancy in approximately 20-25% of cases." | 2.41 | Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. ( Clarke, SJ; Clifford, A; Izard, M; Vardy, J; Wong, E, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vardy, J | 1 |
Wong, E | 1 |
Izard, M | 1 |
Clifford, A | 1 |
Clarke, SJ | 1 |
1 review available for amifostine anhydrous and Anaphylaxis
Article | Year |
---|---|
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
Topics: Amifostine; Anaphylaxis; Combined Modality Therapy; Dermatomyositis; Humans; Magnetic Resonance Imag | 2002 |